Recombinant SOST (Setrusumab Biosimilar) antibody

Catalog No. ABIN7675813

The Human Monoclonal anti-SOST (Setrusumab Biosimilar) antibody (ABIN7675813) specifically detects SOST (Setrusumab Biosimilar) in BLI, ELISA, FACS, Func and SPR. The antibody is reactive with Human samples.

Quick Overview for Recombinant SOST (Setrusumab Biosimilar) antibody (ABIN7675813)

Target: SOST (Setrusumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This SOST (Setrusumab Biosimilar) antibody is un-conjugated

Application: Bio-Layer Interferometry (BLI), ELISA, Flow Cytometry (FACS), Functional Studies (Func), Surface Plasmon Resonance (SPR)

Product Details anti-SOST (Setrusumab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: Anti-SOST / Sclerostin Reference Antibody (setrusumab)

Characteristics: Anti-SOST / Sclerostin Reference Antibody (setrusumab) is expressed from CHO. The heavy chain type is huIgG2, and the light chain type is hulambda. It has a predicted MW of 145.5 kDa.

Purity: >95 %

Isotype: IgG2SA

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Storage: 4 °C,-80 °C

Storage Comment: +4°C,-80°C

Target Details for SOST (Setrusumab Biosimilar)

Target: SOST (Setrusumab Biosimilar)

Target Type: Biosimilar

Molecular Weight: 145.5 kDa

UniProt: Q9BQB4